Neer Sharma

And the distributional thing is validated from, oh yeah, like all of these journalistic publications always write about like, ah, look at what Apple working on. Look at this patent from Apple. So it's like, okay, cool. Like let's just centralize it. Let's own that format. That format right now is not owned by someone. Let's own that format.

So similarly with, um, long live research, it'd be doing the same play, but it would be doing it for academic research that is looking at the extension of life and quality of life. and it just be kind of running it back in theory. But basically, let's say I'm near, I'm South Asian. So problems that I need to avoid are like type two diabetes, maybe some cardiac issues. My father had cancer.

So similarly with, um, long live research, it'd be doing the same play, but it would be doing it for academic research that is looking at the extension of life and quality of life. and it just be kind of running it back in theory. But basically, let's say I'm near, I'm South Asian. So problems that I need to avoid are like type two diabetes, maybe some cardiac issues. My father had cancer.

So similarly with, um, long live research, it'd be doing the same play, but it would be doing it for academic research that is looking at the extension of life and quality of life. and it just be kind of running it back in theory. But basically, let's say I'm near, I'm South Asian. So problems that I need to avoid are like type two diabetes, maybe some cardiac issues. My father had cancer.

So let me just like, I'm interested in cancer. I input all of those um, things. And then, okay. Long live research is just sending me as soon as there is research focused on how to, um, extend life or, you know, reduce the risk of one of those things. It's just sending me the summary. And, um, I think this kind of tacks into the longevity meta trend.

So let me just like, I'm interested in cancer. I input all of those um, things. And then, okay. Long live research is just sending me as soon as there is research focused on how to, um, extend life or, you know, reduce the risk of one of those things. It's just sending me the summary. And, um, I think this kind of tacks into the longevity meta trend.

So let me just like, I'm interested in cancer. I input all of those um, things. And then, okay. Long live research is just sending me as soon as there is research focused on how to, um, extend life or, you know, reduce the risk of one of those things. It's just sending me the summary. And, um, I think this kind of tacks into the longevity meta trend.

I think unlike Patent Drop, like Patent Drop was very much run by advertising. I think long live research is actually something that people would want to spend money on if it's done in a really high quality way. I think there's a lot of money being spent on people trying to extend their life. So having, you know, just...

I think unlike Patent Drop, like Patent Drop was very much run by advertising. I think long live research is actually something that people would want to spend money on if it's done in a really high quality way. I think there's a lot of money being spent on people trying to extend their life. So having, you know, just...

I think unlike Patent Drop, like Patent Drop was very much run by advertising. I think long live research is actually something that people would want to spend money on if it's done in a really high quality way. I think there's a lot of money being spent on people trying to extend their life. So having, you know, just...

instant research kind of brought to you very quickly is something I think people would pay for. Um, so yeah, it's really just kind of applying that, that thesis of, you know, get fragmented information, bring it to people in a way that's relevant to them, um, and make money from that is, is, is the, the, the play I'd be making.

instant research kind of brought to you very quickly is something I think people would pay for. Um, so yeah, it's really just kind of applying that, that thesis of, you know, get fragmented information, bring it to people in a way that's relevant to them, um, and make money from that is, is, is the, the, the play I'd be making.

instant research kind of brought to you very quickly is something I think people would pay for. Um, so yeah, it's really just kind of applying that, that thesis of, you know, get fragmented information, bring it to people in a way that's relevant to them, um, and make money from that is, is, is the, the, the play I'd be making.

Yeah, I think also, you know, I was kind of testing it with Claude and just, you know, feeding it academic papers and just getting results. And it's like, yeah, this is so much easier now with, you know, starting these ideas using Claude or ChatGPT to kind of code an MVP is just so much easier to do today than it was like a few years ago. So I think these kinds of plays are pretty easy to do.

Yeah, I think also, you know, I was kind of testing it with Claude and just, you know, feeding it academic papers and just getting results. And it's like, yeah, this is so much easier now with, you know, starting these ideas using Claude or ChatGPT to kind of code an MVP is just so much easier to do today than it was like a few years ago. So I think these kinds of plays are pretty easy to do.

Yeah, I think also, you know, I was kind of testing it with Claude and just, you know, feeding it academic papers and just getting results. And it's like, yeah, this is so much easier now with, you know, starting these ideas using Claude or ChatGPT to kind of code an MVP is just so much easier to do today than it was like a few years ago. So I think these kinds of plays are pretty easy to do.

Okay, one last idea. Let's rock. What kind of idea do we want?

Okay, one last idea. Let's rock. What kind of idea do we want?

Okay, one last idea. Let's rock. What kind of idea do we want?

That's a great question. I think the... Okay, so I think besides the long-lived research, which I think could be that million dollars within a year. Okay. So the idea I would go for is... Have you heard of Shilajit?